TruNorth Capital Management’s Boston Scientific BSX Stock Holding History

TruNorth Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60	Closed	-$5.86K	–	153
2025 Q3	$5.86K	Sell	60 -41	-41%	-$4.25K	﹤0.01%	367
2025 Q2	$10.8K	Hold	101	–	–	﹤0.01%	285
2025 Q1	$10.2K	Hold	101	–	–	﹤0.01%	364
2024 Q4	$9.02K	Hold	101	–	–	﹤0.01%	288
2024 Q3	$8.46K	Buy	101 +60	+146%	+$4.73K	﹤0.01%	295
2024 Q2	$3.16K	Hold	41	–	–	﹤0.01%	300
2024 Q1	$2.81K	Buy	+41	New	+$2.64K	﹤0.01%	239

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TruNorth Capital Management's BSX Position: Q4 2025 in Review

TruNorth Capital Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 60 shares — an estimated $5.86K sold.

TruNorth Capital Management first reported a position in BSX in Q1 2024 and held it in 7 quarters. The position peaked at $10.8K in Q2 2025. 1,785 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

TruNorth Capital Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
TruNorth Capital Management sold 60 Boston Scientific shares in Q4 2025, an estimated $5.86K.
TruNorth Capital Management first reported a position in Boston Scientific in Q1 2024 and held it in 7 quarters.
TruNorth Capital Management's Boston Scientific position peaked at $10.8K in Q2 2025.
1,785 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.